Skip to content

Comparison for the effect of sleep apnea events during REM and NREM on glucose and insulin resistance

Comparison for the effect of sleep apnea events during REM and NREM on glucose and insulin resistance

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019431
Enrollment
Unknown
Registered
2018-11-10
Start date
2018-10-29
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

OSAS, T2DM

Interventions

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Understanding and willing to participate in this clinical trial and to provide signed informed consent; 2. Aged 18-70 years male and female; 3. Newly diagnosed type 2 diabetes which meet the WHO recommendation (1999) standard;

Exclusion criteria

Exclusion criteria: Using drugs that affect glucose metabolism, unstable cardiopulmonary conditions, liver or renal disease, malignant tumor, neurological disorders, psychiatric disease, shift work, chronic insomnia, or any prior or current treatment for OSA (upper airway surgery, CPAP therapy, oral appliances, or supplemental oxygen), autoimmune disease, glaucoma or high intraocular tension, pregnant or breast-feeding women.

Design outcomes

Primary

MeasureTime frame
Apnea Hyponea Index;oxygen desaturation index;HOMA-IR;Insulin sensitivity index;The 24-h mean blood glucose;Sleep structure;Mean nocturnal oxygen saturation;

Countries

China

Contacts

Public ContactGao Yun

Department of Endocrinology and Metabolism, West China Hospital, Sichuan University

wsgaoyun@126.com+86 18980606855

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026